Navigation Links
Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
Date:5/30/2014

TAMPA, Fla. (May 30, 2014) Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue for several years after treatment, according to an American Society of Clinical Oncology Expert Panel co-chaired by Paul Jacobsen, Ph.D., associate center director of Population Sciences at Moffitt Cancer Center.

ASCO created the panel to develop assessment, screening, and treatment guidelines for medical professionals to help patients who experience fatigue after completing primary treatment. The panel analyzed several national guidelines from the United States and Canada, and reviewed published studies about cancer-related fatigue to create the new guidelines.

The panel recommends that all health care professions regularly screen and measure fatigue and other associated problems in cancer patients through health history, physical examinations, and laboratory analysis. It is important for all patients to be educated about fatigue and its associated medical problems.

Fatigue in cancer patients after treatment can arise from other problems, such as depression, pain, anxiety, nutritional deficits, medications, or emotional distress. The panel recommends that all contributing factors should be identified and treated before the symptoms of fatigue are addressed.

There are a number of treatment and care options for patients experiencing continued fatigue. "Studies show that initiating or maintaining adequate levels of physical activity can reduce cancer-related fatigue in post-treatment patients. Physicians should actively encourage all patients to engage in a moderate level of physical activity after cancer treatment, dependent on risk of injury," said Jacobsen.

Behavioral and psychoeducational therapies have also been reported to reduce fat
'/>"/>

Contact: Kim Polacek
Kim.Polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Moffitt Cancer Centers phase 3 study may be game-changer for acute myeloid leukemia
2. Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
3. Moffitt instrumental in FDA approval of revolutionary 2-drug combo to treat advanced melanoma
4. Moffitt Cancer Center launches prostate cancer study focused on black men
5. Single injection may revolutionize melanoma treatment, Moffitt study shows
6. Moffitt researchers identify gene variations that may help predict cancer treatment response
7. Moffitt Cancer Center expert standardizing guidelines for penile cancer treatment
8. Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
9. Single men, smokers at higher risk for oral human papillomavirus infection, Moffitt study shows
10. How to boost Hispanics participation in clinical trials? Relate to them, Moffitt study shows
11. New screening approach identifies small proteins unique to melanoma cells, Moffitt researcher says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 The Down Syndrome ... Potter from the hit show Glee as the keynote ... Walk in Pleasant Prairie, WI. The event aims to ... in Racine, Kenosha, and Walworth counties. ... join us for this important event," says Dawn Nuoffer, ...
(Date:6/2/2015)... York, NY (PRWEB) June 02, 2015 ... Profemur hip replacement lawsuit ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is ... County. According to court documents, opening statements were ... asserting that laser etchings on the Profemur hip ... fracture, causing it to snap just three years ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Tronics, a ... deploying its growth strategy to benefit from the significant ... Yole Développement’s May 2015 Status of the MEMS Industry ... sharply and reach $6.6B in 2020,” says Frederic Breussin, ... Développement . , The analyst adds that “although the ...
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low power ... new products implementing the ANT+ Fitness Equipment Control (FE-C) ... in their bike trainer products, built to create an ... the FE-C device profile in its Vortex Smart and ... indoor training software, while Kinomap has added FE-C support ...
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
Breaking Medicine News(10 mins):Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2
... with Medtronic delivery and glucose sensing leadership INDIANAPOLIS and ... names in diabetes management -Eli Lilly and Company (NYSE: ... MDT ) - today announced a strategic marketing ... with diabetes manage their blood sugar using insulin therapy.Working ...
... and Data Management Providers Expands Area Market RoleSANTA ... a leading provider of digital radiography (DR), ultrasound, ... management software (VIA(R)) for veterinary care, announced it ... West Coast ultrasound representative. Thorn brings strong animal ...
... brain ,sings, could improve our understanding of conditions such ... scientists at Cardiff University have discovered. , Research ... Imaging Centre (CUBRIC) has discovered that a person,s brain ... when a person looks at a visual pattern. ...
... Television Infrastructure to Enable System Turn-On At Grand ... May 19 LodgeNet Healthcare, a division of ... and the leading provider of interactive patient television ... Television System is now serving patients at the ...
... Policy Actions at the Federal Level , ... (PRWEB) ... more than 200 viral hepatitis groups around the world have planned ... support for improvements in prevention, diagnosis, treatment and support for people ...
... May 19 The Quigley Corporation, (Nasdaq: ... www.quigleyco.com , today announced that it has ... the Company,s Quigley Pharma, Inc. wholly-owned subsidiary COO, Dr. ... of documentary evidence of undisclosed payments from Karkus to ...
Cached Medicine News:Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 2Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 3Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 4Health News:Eklin Medical Systems Appoints Juan Thorn as West Coast Ultrasound Sales Representative 2Health News:'Singing brains' offers epilepsy and schizophrenia clues 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 2Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 2Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 4Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 5
(Date:6/2/2015)... June 2, 2015 Today the Council ... 150 major food companies, retailers, and human and ... on Antibiotic Stewardship. CSTE is committed to supporting ... detect resistant strains, preserve the efficacy of our ... infections. CSTE continues to serve as ...
(Date:6/2/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... from the U.S. Food and Drug Administration (FDA) of ... Oral Solution 5mg/5mL. Trailing twelve-month sales for the product ... competitors. ANI expects to begin shipping to its customers ... and CEO of ANI Pharmaceuticals, stated, "This ANDA represents ...
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... with ORMD-0801, its orally ingestible insulin capsule on type ... sessions in the ADA 75 th Scientific Sessions ... . The poster will be attended by Oramed,s Chief ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
... generation of a hypoxic environment for tissue ... surface-type seal where all portions of the ... steel ring clamp for a reliable air-tight ... and bottom provide minimum gas flow resistance ...
... range of miniTHERM incubators is available, ensuring ... solution for their specific requirements. miniTHERM incubators ... compact and extremely space saving. Their size ... It is possible to stack up to ...
... Steri-Cult has been the leading ... volume cell culture for more ... the name that brought leading ... CO 2 sensors,microprocessor control, ...
Medicine Products: